Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04653324 · ClinicalTrials.gov registry record
A Registry for the Food Allergy Community
A clinical trial of Eosinophilic Esophagitis and Food Hypersensitivity, sponsored by Food Allergy Research & Education.
- Recruiting
- Registry status
- 23,000
- Enrollment target
- 1
- Study location
NCT04653324: Recruiting study of Eosinophilic Esophagitis and Food Hypersensitivity, sponsored by Food Allergy Research & Education.
NCT04653324 is a study of Eosinophilic Esophagitis and Food Hypersensitivity that is actively recruiting participants, run by Food Allergy Research & Education. The registered enrollment target is 23,000 participants, above the 341-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (6645% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04653324, a study of Eosinophilic Esophagitis and Food Hypersensitivity, is actively recruiting participants, sponsored by Food Allergy Research & Education.
- RECRUITING
- Registry status
- 23,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials. The FARE Patient Registry intends to make and support scientific discoveries by enabling the food allergy community to participate directly in research.
Conditions Studied
Study Locations (1)
Virginia
- Food Allergy Research & Education - McLean
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,000 participants |
| Start Date | 2017-08-24 |
| Est. Completion | 2027-08 |
What NCT04653324 shows while recruiting
NCT04653324 is an observational study that tracks outcomes without assigning an intervention. Its 23,000 participants enrollment target places it among the larger protocols in the corpus, above the 341-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (6645% higher).
The record links to 6 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 0 interventions.
NCT04653324 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04653324 about?
NCT04653324 is a clinical study titled "A Registry for the Food Allergy Community". The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials....
What is the current status of trial NCT04653324?
This trial is currently recruiting. The enrollment target is 23,000 participants. The study started on 2017-08-24. Estimated completion is 2027-08.
What conditions does trial NCT04653324 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, Food Hypersensitivity, Food Allergy in Infants, Anaphylaxis, Food Sensitivity.
Who is sponsoring clinical trial NCT04653324?
This trial is sponsored by Food Allergy Research & Education, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04653324 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04653324's enrollment target sits among peer trials
23,000 1st of 44 higher than 44 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
Eosinophilic Gastrointestinal Disorders Registry
RECRUITING
-
Natural History and Genetics of Food Allergy and Related Conditions
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI